Macro, Policy & Capital
ChronoScale (CHRN) completed its Legacy Ekso Business sale after August 31; cloud operations generated 94.1% of August-quarter revenue.
· ComputeLabs Research · from the October 14, 2026 edition
The transition is supported by a quarterly SEC filing. ChronoScale’s Form 10-Q, filed October 14, states that its Cloud Business generated approximately 94.1% of total revenue for the three months ended August 31, 2026. It also states that the Legacy Ekso Business sale was completed after that quarter ended, without specifying the closing date in the supplied excerpt.
The corporate combination preceded the legacy-business disposal. On May 5, 2026, Ekso Bionics Holdings completed the business combination contemplated by a February 15 Contribution and Exchange Agreement involving subsidiaries of Applied Digital. At closing, Ekso changed its name to ChronoScale Corporation, and the contributed Cloud business became its wholly owned subsidiary.
The filing distinguishes the operating transition from an intention to pivot. Following the combination, the company operated both the Cloud Business and the Legacy Ekso Business; the subsequent sale is disclosed as completed. The supplied excerpt does not include sale proceeds, the buyer, transaction-related dilution, or a description of the legacy product business beyond its Ekso identity.
- ChronoScale (CHRN)
- Legacy Ekso Business
- August 31

